These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 32272147)

  • 1. Genomics and precision surgery for head and neck squamous cell carcinoma.
    Galmiche A; Saidak Z; Bouaoud J; Mirghani H; Page C; Dakpé S; Clatot F
    Cancer Lett; 2020 Jul; 481():45-54. PubMed ID: 32272147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leveraging Genomics for Head and Neck Cancer Treatment.
    Kemmer JD; Johnson DE; Grandis JR
    J Dent Res; 2018 Jun; 97(6):603-613. PubMed ID: 29420101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of gene methylation in surgical margin imprints with locoregional recurrence in head and neck squamous cell carcinoma.
    Hayashi M; Wu G; Roh JL; Chang X; Li X; Ahn J; Goldsmith M; Khan Z; Bishop J; Zhang Z; Zhou XC; Richmon J; Agrawal N; Koch WM
    Cancer; 2015 Jun; 121(12):1957-65. PubMed ID: 25773145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic sequencing and precision medicine in head and neck cancers.
    Hoesli RC; Ludwig ML; Michmerhuizen NL; Rosko AJ; Spector ME; Brenner JC; Birkeland AC
    Eur J Surg Oncol; 2017 May; 43(5):884-892. PubMed ID: 28034498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic Correlate of Exceptional Erlotinib Response in Head and Neck Squamous Cell Carcinoma.
    Van Allen EM; Lui VW; Egloff AM; Goetz EM; Li H; Johnson JT; Duvvuri U; Bauman JE; Stransky N; Zeng Y; Gilbert BR; Pendleton KP; Wang L; Chiosea S; Sougnez C; Wagle N; Zhang F; Du Y; Close D; Johnston PA; McKenna A; Carter SL; Golub TR; Getz G; Mills GB; Garraway LA; Grandis JR
    JAMA Oncol; 2015 May; 1(2):238-44. PubMed ID: 26181029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic insights from genomic studies of head and neck squamous cell carcinomas.
    Hammerman PS; Hayes DN; Grandis JR
    Cancer Discov; 2015 Mar; 5(3):239-44. PubMed ID: 25643909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Precision Therapy of Head and Neck Squamous Cell Carcinoma.
    Polverini PJ; D'Silva NJ; Lei YL
    J Dent Res; 2018 Jun; 97(6):614-621. PubMed ID: 29649374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain metastasis from squamous cell carcinoma of the head and neck: a review of the literature in the genomic era.
    Barrett TF; Gill CM; Miles BA; Iloreta AMC; Bakst RL; Fowkes M; Brastianos PK; Bederson JB; Shrivastava RK
    Neurosurg Focus; 2018 Jun; 44(6):E11. PubMed ID: 29852772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term culture of tumour slices reveals the heterogeneous sensitivity of human head and neck squamous cell carcinoma to targeted therapies.
    Donnadieu J; Lachaier E; Peria M; Saidak Z; Dakpe S; Ikoli JF; Chauffert B; Page C; Galmiche A
    BMC Cancer; 2016 Apr; 16():273. PubMed ID: 27085492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular genetics of head and neck squamous cell carcinoma.
    Saada-Bouzid E; Peyrade F; Guigay J
    Curr Opin Oncol; 2019 May; 31(3):131-137. PubMed ID: 30893149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current Trends in Precision Medicine and Next-Generation Sequencing in Head and Neck Cancer.
    Solis RN; Silverman DA; Birkeland AC
    Curr Treat Options Oncol; 2022 Feb; 23(2):254-267. PubMed ID: 35195839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of genetic variants of frequently mutated genes in human papillomavirus-negative primary head and neck squamous cell carcinoma, resection margins, local recurrences and corresponding circulating cell-free DNA.
    Flach S; Kumbrink J; Walz C; Hess J; Drexler G; Belka C; Canis M; Jung A; Baumeister P
    J Oral Pathol Med; 2022 Sep; 51(8):738-746. PubMed ID: 35895622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Research Progress in Head and Neck Squamous Cell Carcinoma: Best Abstracts of ICHNO 2015.
    Economopoulou P; Bourhis J; Psyrri A
    Am Soc Clin Oncol Educ Book; 2015; ():e323-8. PubMed ID: 25993192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted molecular imaging of head and neck squamous cell carcinoma: a window into precision medicine.
    Wu J; Yuan Y; Tao XF
    Chin Med J (Engl); 2020 Jun; 133(11):1325-1336. PubMed ID: 32404691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival.
    Dubot C; Bernard V; Sablin MP; Vacher S; Chemlali W; Schnitzler A; Pierron G; Ait Rais K; Bessoltane N; Jeannot E; Klijanienko J; Mariani O; Jouffroy T; Calugaru V; Hoffmann C; Lesnik M; Badois N; Berger F; Le Tourneau C; Kamal M; Bieche I
    Eur J Cancer; 2018 Mar; 91():47-55. PubMed ID: 29331751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Illuminating biological pathways for drug targeting in head and neck squamous cell carcinoma.
    Choonoo G; Blucher AS; Higgins S; Boardman M; Jeng S; Zheng C; Jacobs J; Anderson A; Chamberlin S; Evans N; Vigoda M; Cordier B; Tyner JW; Kulesz-Martin M; McWeeney SK; Laderas T
    PLoS One; 2019; 14(10):e0223639. PubMed ID: 31596908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward the use of precision medicine for the treatment of head and neck squamous cell carcinoma.
    Gong W; Xiao Y; Wei Z; Yuan Y; Qiu M; Sun C; Zeng X; Liang X; Feng M; Chen Q
    Oncotarget; 2017 Jan; 8(2):2141-2152. PubMed ID: 27924064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted sequencing reveals TP53 as a potential diagnostic biomarker in the post-treatment surveillance of head and neck cancer.
    van Ginkel JH; de Leng WW; de Bree R; van Es RJ; Willems SM
    Oncotarget; 2016 Sep; 7(38):61575-61586. PubMed ID: 27528217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and genomic characterization of neutral tumor evolution in Head and Neck Squamous Cell Carcinoma.
    Li R; Dong J; Zhang H; Zhao Q; Li X; Liu X; Ye Y; Deng S; Lin D; Zheng J; Zuo Z
    Genomics; 2020 Sep; 112(5):3448-3454. PubMed ID: 32569729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune signaling-based Cascade Propagation approach re-stratifies HNSCC patients.
    Liu K; Chyr J; Zhao W; Zhou X
    Methods; 2016 Dec; 111():72-79. PubMed ID: 27339942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.